Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
funding
national blog main
acerta pharma
adage capital management
antibody drugs
antibody-drug conjugate
arix
arix bioscience
astrazeneca
biotech
bispecific antibodies
calistoga pharmaceuticals
cancer
citadel
clayton knox
clinical trials
cormorant asset management
dave johnson
decheng capital
farallon
financing
foresite capital
funds and accounts advised by t. rowe price associates
gilead sciences
janus henderson investors
jlabs
johnson & johnson
langdon miller
life sciences
logos capital
matrix capital management
mavupharma
national
orbimed
pappas capital
reata pharmaceuticals
ror1
san diego
san diego blog main
What
advance
drug
2
×
drugs
2
×
antibody
based
cancer
candidates
ceo
closed
company’s
dave
development
diego
disease
johnson
kipps
known
lead
million
nearly
pharmaceuticals
physician
raising
rakes
rare
reata
regulatory
reseacher
review
ror
san
stock
tacks
targeting
thomas
tuesday
uc
velosbio
years
Language
unset
Current search:
drug
×
drugs
×
abbvie
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}